Valuation: Enimmune corporation

Market Cap 120.1Cr 3.71Cr 3.26Cr 3.03Cr 2.78Cr 5.23Cr 357.53Cr 5.31Cr 36Cr 14Cr 175.77Cr 14Cr 14Cr 607.74Cr P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 114.64Cr 3.54Cr 3.11Cr 2.89Cr 2.66Cr 4.99Cr 341.28Cr 5.07Cr 34Cr 13Cr 167.78Cr 13Cr 13Cr 580.11Cr EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
28.72%
Yield 2024 *
-
Yield 2025 -
1 week+2.78%
Current month+4.06%
1 month+7.77%
3 months-14.40%
6 months-17.16%
Current year-19.17%
1 week 16.25
Extreme 16.25
17.1
1 month 15.4
Extreme 15.4
17.1
Current year 15.4
Extreme 15.4
22.15
1 year 15.4
Extreme 15.4
23.9
3 years 14.65
Extreme 14.65
49.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 07/01/2019
Chief Tech/Sci/R&D Officer - 21/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 07/01/2019
Director/Board Member - 02/01/2014
Director/Board Member - 19/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.78%-1.48%-64.80% 3.71Cr
-0.32%+6.50%+56.82%+71.09% 5.73TCr
-1.92%+6.03%+40.64%+80.66% 5.5TCr
-0.46%-1.29%+2.86%+425.15% 2.32TCr
-2.97%-2.35%-22.53%-15.34% 2.26TCr
-1.13%+1.05%+20.81%-7.73% 2.05TCr
+0.15%+1.79%+25.54%-30.11% 1.76TCr
-0.10%+1.88%+34.42%+545.91% 1.57TCr
-1.30%-5.02%+170.77%+310.94% 1.45TCr
-0.50%-0.98%+21.43%+179.36% 1.39TCr
Average -0.84%+1.18%+34.93%+149.51% 2.4TCr
Weighted average by Cap. -1.02%+2.10%+38.43%+136.88%

Financials

2024 2025
Net sales 3.99Cr 12.34L 10.84L 10.08L 9L 17.38L 12Cr 17.64L 1.2Cr 46.76L 5.84Cr 46.32L 45.32L 20Cr 4.82Cr 14.9L 13.08L 12.17L 11.17L 20.98L 14Cr 21.3L 1.44Cr 56.45L 7.05Cr 55.93L 54.72L 24Cr
Net income -16Cr -48.7L -42.77L -39.78L -36.5L -68.58L -47Cr -69.64L -4.72Cr -1.85Cr -23Cr -1.83Cr -1.79Cr -80Cr -16Cr -50.8L -44.62L -41.5L -38.08L -71.54L -49Cr -72.65L -4.93Cr -1.93Cr -24Cr -1.91Cr -1.87Cr -83Cr
Net Debt -38Cr -1.18Cr -1.04Cr -96.45L -88.51L -1.66Cr -113.72Cr -1.69Cr -11Cr -4.47Cr -56Cr -4.43Cr -4.34Cr -193.3Cr -5.46Cr -16.88L -14.82L -13.78L -12.65L -23.77L -16Cr -24.13L -1.64Cr -63.95L -7.99Cr -63.35L -61.99L -28Cr
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
24/26/24 NT$16.65 0.00% 38,305
23/26/23 NT$16.65 -0.89% 38,561
22/26/22 NT$16.80 +3.07% 1,11,227
21/26/21 NT$16.30 -1.81% 1,20,785
20/26/20 NT$16.60 +2.47% 1,40,006
  1. Stock Market
  2. Stocks
  3. 6564 Stock